# Nuclide record pfizer (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/pfizer/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "pfizer" ;
  schema:name "Pfizer (incl. Seagen)"@en ;
  schema:alternateName "Seagen"@en, "Seagen (Pfizer)"@en, "Seattle Genetics"@en ;
  schema:description "Bought Seagen for $43B to become an ADC leader; also makes Ibrance, Lorbrena, Braftovi, and the first PROTAC."@en ;
  schema:url <https://nuclide.cc/companies/pfizer/>, <https://www.pfizer.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.pfizer.com> ;
  schema:addressCountry "US" ;
  nuclide:drugs <https://nuclide.cc/drugs/dexrazoxane/> .
